@article{TCR20960,
author = {Silvia Vecchiarelli and Lorenza Landi and Federico Cappuzzo},
title = {Atezolizumab: state of art and future perspective in non-small cell lung cancer treatment},
journal = {Translational Cancer Research},
volume = {7},
number = {Suppl 5},
year = {2018},
keywords = {},
abstract = {Lung cancer is the first cause of cancer deaths worldwide (1). Nowadays, treatment landscape of non-small cell lung cancer (NSCLC) is rapidly changing by the introduction of immune-checkpoint inhibitors (2,3).},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/20960}
}